Analysts at HSBC initiated coverage on shares of Genus (LON:GNS) in a report released on Tuesday. The firm set a “buy” rating and a GBX 2,650 ($34.63) price target on the stock. HSBC’s target price points to a potential upside of 15.02% from the stock’s previous close.
A number of other brokerages have also recently weighed in on GNS. Peel Hunt reiterated a “hold” rating on shares of Genus in a report on Thursday, November 15th. Liberum Capital reiterated a “hold” rating on shares of Genus in a report on Thursday, November 15th. Finally, Kepler Capital Markets upgraded Genus to a “buy” rating and lifted their target price for the company from GBX 2,475 ($32.34) to GBX 2,630 ($34.37) in a report on Thursday, December 6th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of GBX 2,416 ($31.57).
Shares of Genus stock opened at GBX 2,304 ($30.11) on Tuesday. Genus has a twelve month low of GBX 1,652 ($21.59) and a twelve month high of GBX 2,597 ($33.93).
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Article: How To Calculate Debt-to-Equity Ratio
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.